Copertina

Machine Learning‐Based Prediction of Drug‐Induced QTc Changes in a Large Finnish Biobank Cohort

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Ville Langén, Aleksi Winstén, Konsta Teppo, Timo Pohjonen, Jari Laukkanen, Arto Mannermaa, Teemu J. Niiranen, Joonatan Palmu
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Clinical and Translational Science
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

jjmpal/cad_causality: v1.0
di: Joonatan Palmu
Pubblicazione: (2025)

Concentration–QTc Analysis of Valemetostat in Patients With Hematologic Malignancies
di: Masaya Tachibana, et al.
Pubblicazione: (2025)

White Matter Hyperintensity Burden and Short‐Interval Change Associated With Sleep Apnoea in the UK Biobank
di: Peng Cheng, et al.
Pubblicazione: (2026)

Effects of Nacubactam and Its Metabolites on QTc Interval: A Pooled Analysis of Two Randomized Phase 1 Studies
di: Jun Morita, et al.
Pubblicazione: (2026)

A phase I thorough QT/QTc study evaluating therapeutic and supratherapeutic doses of avacopan in healthy participants
di: Shichang Miao, et al.
Pubblicazione: (2024)

Machine learning identifies fatigue as a key symptom of fibromyalgia reflected in tyrosine, purine, pyrimidine, and glutaminergic metabolism
di: Teemu Zetterman, et al.
Pubblicazione: (2024)

Concentration‐QTcF analysis of quizartinib in patients with newly diagnosed FLT3‐internal‐tandem‐duplication‐positive acute myeloid leukemia
di: Pavan Vaddady, et al.
Pubblicazione: (2024)

APOE Genotype and Statin Response: Evidence From the UK Biobank and All of Us Program
di: Innocent G. Asiimwe, et al.
Pubblicazione: (2025)

Utility of Patch Testing, LTT, and HLA Genotyping in Identifying Culprit Drugs and Diagnosing Multiple Drug Hypersensitivity in Definite DRESS: A 10‐Year Cohort Study
di: Derya Ünal, et al.
Pubblicazione: (2026)

Myths and challenges around anticoagulation in atrial fibrillation: A practicing clinician's perspective
di: K. E. Juhani Airaksinen, et al.
Pubblicazione: (2025)

Predictors of revision endoscopic sinus surgery in Finnish patients with chronic rhinosinusitis with nasal polyps
di: Sanna Toppila‐Salmi, et al.
Pubblicazione: (2025)

Development and Validation of an Approach to Assessing Clinical Relevance of Potential Drug–Drug Interactions Inducing Rare but Serious Adverse Events
di: Menghuan Song, et al.
Pubblicazione: (2025)

Utilization of Machine Learning Approaches for Drug Clearance Prediction and Population Pharmacokinetic Covariate Analysis
di: Atul Rawal, et al.
Pubblicazione: (2025)

Tutorial Drug–Drug Interactions
di: Edward M. Sellers
Pubblicazione: (2025)

Navigating Drug–Drug Interactions in Clinical Drug Development: A Tutorial
di: Jesmin Lohy Das, et al.
Pubblicazione: (2025)

Evaluation of Elexacaftor/Tezacaftor/Ivacaftor‐Mediated Drug‐Induced Liver Injury Using a Liver‐On‐Chip Model
di: Alan Shi, et al.
Pubblicazione: (2025)

Clinical Evaluation of Drug–Drug Interactions With Aficamten
di: Neha Maharao, et al.
Pubblicazione: (2026)

Sputum Eosinophil and Macrophage Changes After Aspirin Challenge in Patients With Nonsteroidal Anti‐Inflammatory Drug–Exacerbated Respiratory Disease
di: Gabriela Trąd‐Wójcik, et al.
Pubblicazione: (2025)

Non‐targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 function
di: Kreetta Hämäläinen, et al.
Pubblicazione: (2024)

Prevalence of OATP1B‐Mediated Drug–Drug Interactions in an Academic Medical Center
di: Mathilde Bories, et al.
Pubblicazione: (2025)

Implementation of Rapid Drug Desensitization in Antineoplastic Drug Therapy in Denmark Using One‐Bag Protocols
di: Trine Holm Rasmussen, et al.
Pubblicazione: (2025)

Assessment of Food Effect and pH‐Dependent Drug–Drug Interactions of Fruquintinib in Healthy Subjects
di: Martha Gonzalez, et al.
Pubblicazione: (2025)

Clinical Significance of Drug–Drug Interaction Studies During Therapeutic Peptide Drug Development: Follow‐Up Investigation of Therapeutic Peptides Approved Between 2021 and 2024
di: Carolina Säll, et al.
Pubblicazione: (2025)

Characterization of Drug–Drug Interactions for Remdesivir, an Intravenous Antiviral for SARS‐CoV‐2, in Healthy Participants
di: Jack Chang, et al.
Pubblicazione: (2025)

Translation norms in the light of practical research in literary translation
di: Mercedes Enríquez-Aranda
Pubblicazione: (2016)

Promising Drugs Require Proper Testing
di: Jean‐Jacques Parienti
Pubblicazione: (2026)

Population Pharmacokinetic Model Assessment of the Effects of Body Weight on Risk of Drug–Drug Interactions After Posaconazole Discontinuation
di: Rebecca E. Wrishko, et al.
Pubblicazione: (2026)

Predictive Analysis for First Submission of Generic Drug Application for Orphan Drug Products Using Random Survival Forest
di: Robert Hopefl, et al.
Pubblicazione: (2025)

Prediction of Cisplatin‐Induced Acute Kidney Injury Using an Interpretable Machine Learning Model and Electronic Medical Record Information
di: Kaori Ambe, et al.
Pubblicazione: (2025)

Use of Biomarkers in Drug Development for Regulatory Purposes
di: Robert N. Schuck, et al.
Pubblicazione: (2025)

Exploratory Evaluation of Solanidine as an Endogenous Marker for CYP2D6 ‐Mediated Drug–Drug–Gene Interactions of Venlafaxine in Koreans
di: Sungyeun Bae, et al.
Pubblicazione: (2026)

Effect of Valemetostat on the Pharmacokinetics of Midazolam and Digoxin: A Phase 1 Drug–Drug Interaction Study in Patients With Non‐Hodgkin Lymphoma
di: Masaya Tachibana, et al.
Pubblicazione: (2025)

Fibrinogen Changes Before and After Intravenous Thrombolysis as Predictors of Cerebral Injury and Clinical Outcomes in Acute Ischemic Stroke: A Multicenter Prospective Cohort Study
di: Wenhai Zhai, et al.
Pubblicazione: (2025)

Risk Factors Analysis of Cutaneous Adverse Drug Reactions Caused by Targeted Therapy and Immunotherapy Drugs for Oncology and Establishment of a Prediction Model
di: Zimin Zhang, et al.
Pubblicazione: (2025)

The rise of marine fungi: Drug discovery's blue frontier
di: Eva Breyer, et al.
Pubblicazione: (2026)

Retrospective Analysis of Master Protocols in Tumor‐Agnostic Drug Development: Evaluation of Application to Single‐Agent Therapies With ORR as the Endpoint for Approval of Oncology Drugs
di: Keiko Yamamoto, et al.
Pubblicazione: (2025)

Association between aortic calcification and cytokine levels in patients with peripheral artery disease
di: Ville Rantasalo, et al.
Pubblicazione: (2024)

Self‐Reported Pharmacogenetic Medication Use in the Our Future Health Cohort
di: Padraig Dixon, et al.
Pubblicazione: (2026)

Being born in autumn or winter is associated with asthma and allergic rhinitis in Finland
di: Riikka Hänninen, et al.
Pubblicazione: (2024)

Empirical Drug Dosage Validates Pharmacogenomic Associations in All of Us
di: Jan Matthias, et al.
Pubblicazione: (2025)